TRT and Type 2 Diabetes: Blood Sugar, Insulin Sensitivity & Clinical Evidence (2026 Review)

TRT and Type 2 Diabetes: What the Research Actually Shows

If you have low testosterone and type 2 diabetes — or you’re prediabetic — you’ve probably wondered whether testosterone replacement therapy helps, hurts, or makes no difference to your blood sugar. It’s a fair question. Diabetes and low testosterone frequently travel together, and the relationship between the two is more complex than most people realize.

Here’s what the clinical evidence actually says — no cherry-picking, no hype, just the data.

The Two-Way Relationship Between Testosterone and Diabetes

Low testosterone and type 2 diabetes have a bidirectional relationship — each one makes the other worse:

• Obesity drives both: Excess visceral fat increases aromatase activity, converting testosterone to estrogen, which suppresses the hypothalamic-pituitary-gonadal (HPG) axis and lowers testosterone production.
• Insulin resistance suppresses testosterone: Insulin resistance at the Leydig cell level directly impairs testosterone synthesis. Men with poorly controlled diabetes have significantly lower total and free testosterone levels than age-matched controls without diabetes.
• Low testosterone worsens insulin resistance: Testosterone promotes lean muscle mass and reduces visceral fat. When testosterone drops, body composition shifts toward more fat and less muscle — exactly the metabolic profile that drives insulin resistance.

The prevalence numbers are striking: approximately 33-50% of men with type 2 diabetes have clinically low testosterone, roughly double the rate in the general male population. And the relationship is dose-dependent — worse glycemic control correlates with lower testosterone levels.

What the Major Clinical Trials Show

The T4DM Trial (2021) — The Landmark Study

The Testosterone for the Prevention of Type 2 Diabetes Mellitus (T4DM) trial was a large, multi-center, randomized, double-blind, placebo-controlled study of 1,007 men aged 50-74 with prediabetes or newly diagnosed type 2 diabetes and low testosterone. Over 2 years, men receiving testosterone undecanoate injections showed:

• 40% reduction in the risk of progressing from prediabetes to type 2 diabetes vs placebo
• Significant reduction in fasting glucose
• Improved HOMA-IR (insulin resistance index)
• Reduction in visceral adipose tissue
• Increased lean body mass

This was a game-changer. T4DM demonstrated that testosterone therapy — combined with a lifestyle program — significantly reduced diabetes risk in men with low testosterone. It’s the strongest evidence we have that TRT addresses both the hormonal deficiency AND the metabolic dysfunction simultaneously.

Meta-Analysis Evidence

A 2023 meta-analysis of 18 randomized controlled trials examining TRT’s effect on glycemic control in men with type 2 diabetes and hypogonadism found:

• Significant reduction in HbA1c (glycated hemoglobin — the 3-month blood sugar average)
• Significant reduction in fasting glucose
• Significant reduction in HOMA-IR
• Greater effects in men with poorer baseline glycemic control
• Greater effects with longer treatment duration (>12 months)

The clinical takeaway: TRT improves glycemic control in hypogonadal men with type 2 diabetes, and the benefits accumulate over time. This isn’t a quick fix — it’s a metabolic recalibration that takes months to fully manifest.

The BLAST Study and Other Key Trials

The BLAST study (2016) randomized hypogonadal men with type 2 diabetes to placebo, testosterone gel, or testosterone injections over 30 weeks. Results showed:

• HbA1c improvement only in the injection group (not gel) — suggesting that achieving adequate serum testosterone levels matters
• Significant improvements in sexual function, mood, and quality of life across both treatment groups
• No significant adverse cardiovascular events

This highlights an important clinical point: delivery method matters. Injectable testosterone achieves more consistent and higher serum levels than topical gels, which may explain why the metabolic benefits were stronger with injections.

Mechanisms: HOW TRT Improves Insulin Sensitivity

TRT doesn’t work through a single mechanism — it affects multiple metabolic pathways simultaneously:

1. Body composition shift: TRT increases lean muscle mass and decreases visceral fat. Muscle is the primary site of glucose disposal, and more muscle means better glucose clearance. Less visceral fat means less inflammatory adipokine production that drives insulin resistance.
2. Direct insulin signaling effects: Testosterone receptors are present on pancreatic beta cells and insulin-sensitive tissues. Androgen signaling enhances GLUT4 translocation (the glucose transporter that moves glucose into cells) and improves insulin receptor substrate (IRS) function.
3. Mitochondrial function: Testosterone promotes mitochondrial biogenesis in skeletal muscle — essentially, it increases the number of cellular power plants that burn glucose and fatty acids for energy. More mitochondria = better metabolic flexibility.
4. Reduction in inflammatory adipokines: Visceral fat is an endocrine organ that pumps out inflammatory cytokines (TNF-alpha, IL-6, resistin) that directly cause insulin resistance. By reducing visceral fat, TRT reduces the inflammatory burden that drives metabolic dysfunction.
5. Adiponectin increase: Adiponectin is an insulin-sensitizing hormone produced by fat cells — but paradoxically, levels are LOWER in obesity and type 2 diabetes. TRT has been shown to increase adiponectin levels, enhancing insulin sensitivity at the whole-body level.

Practical Considerations for Diabetic Men Considering TRT

1. Get comprehensive labs first. You need at minimum: total and free testosterone, SHBG, estradiol (sensitive), CBC, CMP, HbA1c, fasting insulin, fasting glucose, lipid panel, PSA. Don’t start TRT based on symptoms alone — confirm the diagnosis with morning labs drawn before 10 AM on two separate occasions.

2. Address lifestyle factors concurrently. TRT amplifies the benefits of exercise and nutrition — it doesn’t replace them. The T4DM trial combined TRT with a lifestyle intervention program. Men who did both got the largest benefits. Resistance training is particularly important for maximizing the muscle-building and glucose-disposal benefits of TRT.

3. Monitor hematocrit and PSA. TRT can increase red blood cell production (erythrocytosis) — particularly relevant for diabetic men who already have elevated cardiovascular risk. Quarterly monitoring of hematocrit is standard of care. If hematocrit exceeds 54%, therapeutic phlebotomy or dose adjustment is indicated.

4. Expect glucose improvements to take months. Body composition changes from TRT take 3-6 months to meaningfully affect HbA1c. Don’t stop your diabetes medications without physician supervision. As insulin sensitivity improves, your diabetes medication doses may need adjustment — this should be coordinated with the physician managing your diabetes.

5. Injection over gel if diabetes is a primary concern. The BLAST study data suggest injections achieve more consistent testosterone levels and may produce stronger metabolic benefits than topical gels. Discuss delivery method with your TRT provider.

Bottom Line

The clinical evidence is clear: TRT improves glycemic control, insulin sensitivity, and body composition in men with low testosterone and type 2 diabetes or prediabetes. The T4DM trial demonstrated a 40% reduction in progression from prediabetes to diabetes with TRT plus lifestyle intervention. Meta-analysis data confirm significant improvements in HbA1c, fasting glucose, and insulin resistance, with benefits accumulating over time.

But TRT is medical treatment — not a supplement. It requires diagnosis via comprehensive labs, physician supervision, quarterly safety monitoring, and a concurrent commitment to nutrition and exercise. Done correctly, it addresses both the hormonal deficiency AND the metabolic dysfunction in a way that few single interventions can match.

Have type 2 diabetes or prediabetes and suspect low testosterone? Schedule a free consultation at Viking Alternative Medicine. Comprehensive labs, board-certified physicians, and a clinical team experienced in managing the testosterone-diabetes intersection.